Content
All Posts > Content under Pharma/Biotech
Week In Review: PAG Pays $540 Million For 58% Stake In Hisun BioRay, A China Biotech
Article By:
ChinaBio® Today
Read
Saturday, September 7, 2019 4:35 PM EDT
PAG, a Hong Kong PE firm, will pay $540 million to acquire a 58% stake in Hisun BioRay, a China biologics company developing autoimmune and oncology drugs.
CGC: Better Safe Than Sorry
Article By:
Christian Stoyanov
Read
Saturday, September 7, 2019 3:52 PM EDT
Recently Canopy Growth Corp. (CGC) has reached its 12 month low, mainly due to excessive cash burns and disappointing results. Even so, I do not find solid underlying company fundamentals for investing in it.
In this article: CGC
Bellicum Is Worth A Look With Multiple Catalysts On The Way In 2nd Half Of 2019
Article By:
Terry Chrisomalis
Read
Thursday, September 5, 2019 8:46 AM EDT
Bellicum is a highly undervalued biotech. Especially, when you consider that it has two types of technology that can be utilized to potentially alter how CAR-T therapies are produced.
In this article: BLCM
The Stock Market Stands On A Precarious Scaffold
Article By:
Michele Schneider
Read
Sunday, September 1, 2019 10:15 AM EDT
In the current market, the price action and negative phases in the indices hang precariously. The bulls, nevertheless, continue to trust the scaffolding of low interest rates, hope for a resolution of tariffs and positive economic statistics.
Week In Review: HiFiBiO Raises $67 Million For Immune Modulator Portfolio
Article By:
ChinaBio® Today
Read
Saturday, August 31, 2019 4:14 PM EDT
Biotheus, a Guangdong biopharma, signed a $142 million deal for China rights to three bi-specifics based on a TNFR antibody from Alligator Bio of Stockholm.
In this article: LLY
Week In Review: Biotheus Acquires China Rights To Three Bi-specifics In $142 Million Deal
Article By:
ChinaBio® Today
Read
Saturday, August 24, 2019 5:15 PM EDT
Biotheus, a Guangdong biopharma, signed a $142 million deal for China rights to three bi-specifics based on a TNFR antibody from Alligator Bio of Stockholm.
In this article: LLY
Stock Charts To Watch - August 19, 2019
Video By:
Harry Boxer
Watch
Monday, August 19, 2019 5:14 PM EDT
Amyris, Inc. had a really good session on Monday, jumping 74 cents, or 20%, to 4.41, on 1.5 million shares. Arrowhead Pharmaceuticals, Neogen Corp., Perion Network, SunPower Corp., and XPO Logistics look good as well. Let's take a closer look
Week In Review: Chipscreen Gains 367% Following $148 Million Shanghai STAR IPO
Article By:
ChinaBio® Today
Read
Saturday, August 17, 2019 4:06 PM EDT
China's Chipscreen Bio traded 367% higher following its $148 million IPO on the Shanghai STAR exchange, raising its market cap to $4.2 billion.
Cannabis Central: Canopy Growth Reports Q1 Revenue Up 249% But Net Loss Up 1,308% - Stock Tanks
Article By:
Lorimer Wilson
Read
Friday, August 16, 2019 7:59 AM EDT
Canopy Growth Q1 Corp. announced its Q1 financial results for the first quarter on Wednesday but the market did not take kindly to what it reported. The stock has dropped 20% in the last 2 days (-14% on Thursday alone).
In this article: CGC
Cannabis Central: Tilray, Inc. Reports Major Q2 Net Loss - Stock Drops More Than 20%
Article By:
Lorimer Wilson
Read
Thursday, August 15, 2019 4:12 PM EDT
Shares of Tilray, Inc. (TLRY) dropped 15% on Wednesday after reporting a net loss of US$35.1M for Q2 and fell another 10% today.
In this article: TLRY
Bull Of The Day: GW Pharmaceuticals (GWPH)
Article By:
Kevin Cook
Read
Thursday, August 15, 2019 6:20 AM EDT
GWPH crushed the sales number for the treatment of two rare forms of pediatric epilepsy with $68 million vs. consensus of $45M.
In this article: GWPH